Researchers have identified a strong association between telomerase reverse transcriptase, an antigen abundantly produced in roughly 85% of tumor cells, and elevated levels of white blood cells that produce antibodies within tumors.
It’s too early to know which treatments for post-viral smell loss may specifically benefit COVID-19-related olfactory dysfunction but here are some treatment options currently in use or in research.
A new clinical trial aims to find out if sentinel lymph node biopsy or elective neck dissection is the best management option for early-stage oral cancer.